JASPER THERAPEUTICS, INC.

Insiders Jasper Therapeutics, Inc.

Equities

JSPR

US4718712023

Market Closed - Nasdaq Other stock markets 01:30:00 21/05/2024 am IST			5-day change	1st Jan Change
23.23 ^USD	+0.91%		+11.90%	+194.42%

13/05	Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4	MT
07/05	Certain Restricted Stock Units of Jasper Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jasper Therapeutics, Inc. Announces Board Changes	01/11	CI
Jasper Therapeutics Appoints Herb Cross as CFO	25/23/25	MT
Jasper Therapeutics, Inc. Appointed Herb Cross, as Corporate Secretary	25/23/25	CI
Jasper Therapeutics Strengthens Management Team with Key Appointments	03/23/03	CI
Jasper Therapeutics, Inc. Appoints Scott Brun to Its Board of Directors	20/23/20	CI
Jasper Therapeutics, Inc. Announces Appointment of Edwin J. Tucker as Chief Medical Officer	13/23/13	CI
Jasper Therapeutics, Inc. Announces Appointment of Stephen J. Galli to Scientific Advisory Board	10/23/10	CI
Jasper Therapeutics, Inc. Appoints David Hinds as Senior Vice President, Development Operations	11/23/11	CI
Jasper Therapeutics, Inc. Appoints Daniel Adelman as Acting Chief Medical Officer	23/23/23	CI
Jasper Therapeutics, Inc. Appoints Vishal Kapoor as Class I Director	17/23/17	CI
Insider Sell: Jasper Therapeutics	29/22/29	MT
Jasper Therapeutics Promotes Jeet Mahal to COO	21/22/21	MT
Jasper Therapeutics, Inc. Announces Management Changes to Strengthen Leadership Team	21/22/21	CI
Jasper Therapeutics Names New CEO; Shares Climb	28/22/28	MT
Jasper Therapeutics, Inc. Announces Executive Changes	28/22/28	CI
Jasper Therapeutics, Inc. Announces CEO Changes	28/22/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW